Led · Series A · Jun 2022

Immuneel Therapeutics develops CAR-T cell therapies, including Qartemi, aimed at treating blood cancers. The company describes CAR-T as a process that extracts a patient’s immune cells, modifies them to target cancer cells, and reinfuses them. Immuneel was founded in Bengaluru in 2019 and is led by Kiran Mazumdar-Shaw. Financially, the company recently raised Rs 100 crore ($10.5 million) in a Series B and previously secured $15 million in a 2022 Series A. Immuneel plans to use the new capital to ramp up production capacity for Qartemi and to expand its commercial or clinical efforts into Southeast Asia and the Middle East.

Participated · Equity · Aug 2021

QuEST Global provides product engineering and lifecycle services across diverse industries, positioning itself as a strategic engineering partner rather than a low-cost provider. The company emphasizes deep engineering expertise and works with customers on emerging technologies amid broad digital disruption in its sector. Investors highlighted QuEST’s ability to scale accounts and become the core engineering partner to top global firms. The recent transaction involved the sale of shares by the co-founders and management team. Existing investors Bain Capital, Advent and GIC remain invested in the business. Management framed the investment as validation of the value created for shareholders and employees. QuEST Global Services Pte Ltd provides outsourced engineering services and specializes in establishing dedicated low-cost engineering centers for global engineering majors. It serves customers across aerospace and defense, aero engines, power generation, oil & gas and industrial products. The company plans to use the new funding to develop its infrastructure and strengthen its position in its core business. QuEST operates delivery centers across India, USA, Italy, Japan, Germany, France, Spain and the UK. The firm employs over 2,000 people and focuses on supporting large engineering customers with offshore and nearshore engineering capabilities.

Participated · Series F · May 2019

EtechAces is the holding company for consumer-facing brands PolicyBazaar, PaisaBazaar, DocPrime and QuickFIXcars. The company has secured the first tranche of a previously announced $236 million Series F round, receiving $152.11 million led by SoftBank Vision Fund. The tranche saw participation from InfoEdge via its subsidiaries Diphda Internet Services and Startup Investments (Holding), and from True North. Instrumentation for the tranche included Series F CCCPS and a small number of equity shares. After this tranche the parent’s valuation stands at $950.76 million; the company expects the remaining $84–86 million to close in a subsequent tranche which should push valuation over $1 billion. Secondary transactions worth about $30 million are also reported to be in the pipeline, and the remaining inbound capital reportedly includes a residual $82 million from SoftBank alongside mentions of PremjiInvest, Tiger Global, and Temasek.

Participated · Equity · Mar 2017

Fincare is an umbrella holding company that manages financial services businesses offering microfinance loans, micro‑enterprise loans and bank‑partnership loans via group companies Disha Microfin, Future Financial Services and Lok Management Services. Its primary product is a joint‑liability group loan that the platform says reaches over 12 lakh customers, 95% of whom are based in rural areas. The platform reports INR 1,735 crore in assets under management and a 79% annual growth rate in AUM over the last three years, and operates more than 270 offices in seven states. Fincare serves over 10 lakh customers and is headquartered in Bangalore. Management has signaled plans to transition Disha Microfin (which received in‑principle RBI approval to become a Small Finance Bank) into a full‑scale bank with deposit‑taking functions to expand product offerings and customer relationships. The company emphasizes digitally enabled infrastructure to support accelerated growth and deeper financial inclusion for underserved rural communities.

Led · Equity · Dec 2015

Cloudnine Hospitals is a Bengaluru-based chain focused on maternity and infant care. The company operates hospitals specialising in maternal and neonatal services. The article reports India Value Fund Advisors invested Rs.400 crore (~$60m) for a significant minority stake. The investment joins existing investors Matrix Partners India and Sequoia India on the cap table. The article does not disclose operating metrics, a valuation, or future plans. No additional financial details were provided in the report. Kids Clinic India operates the Cloudnine chain of premium mother and childcare centres, offering maternity, infant and IVF services. The company currently runs five healthcare facilities in Bangalore and is launching a new facility in Chennai. Cloudnine reports a zero percent maternal mortality rate and a 99.72% survival rate for babies across 16,000 deliveries; its IVF success rate is 42.31%. The company runs Cloudnine in partnership with property developer Scrips N Scrolls India. Management says it will deploy new capital within the next four to six months and plans accelerated geographic expansion. Leadership has indicated plans to set up 10 more centres in southern and western India over the next two years and to invest roughly Rs 300–450 crore to build 15 hospitals in two to three years.